Thromboprophylaxis of Patients with JAK2-Positive Myeloproliferative Neoplasms
Patients with JAK2-positive myeloproliferative neoplasms (JAK2MPN) form a rare patient population, at increased risk of arterial and venous thrombosis. Limited research is available to guide the thromboprophylaxis of these patients. Nonetheless, guidelines and expert opinions recommend the use of lo...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
Université d'Ottawa / University of Ottawa
2021
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10393/42882 http://dx.doi.org/10.20381/ruor-27099 |